GB202118144D0 - Bicyclic peptide ligands specific for cathepsin G - Google Patents

Bicyclic peptide ligands specific for cathepsin G

Info

Publication number
GB202118144D0
GB202118144D0 GBGB2118144.1A GB202118144A GB202118144D0 GB 202118144 D0 GB202118144 D0 GB 202118144D0 GB 202118144 A GB202118144 A GB 202118144A GB 202118144 D0 GB202118144 D0 GB 202118144D0
Authority
GB
United Kingdom
Prior art keywords
cathepsin
peptide ligands
ligands specific
bicyclic peptide
bicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2118144.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleRD Ltd
Original Assignee
BicycleRD Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BicycleRD Ltd filed Critical BicycleRD Ltd
Priority to GBGB2118144.1A priority Critical patent/GB202118144D0/en
Publication of GB202118144D0 publication Critical patent/GB202118144D0/en
Ceased legal-status Critical Current

Links

GBGB2118144.1A 2021-12-15 2021-12-15 Bicyclic peptide ligands specific for cathepsin G Ceased GB202118144D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2118144.1A GB202118144D0 (en) 2021-12-15 2021-12-15 Bicyclic peptide ligands specific for cathepsin G

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2118144.1A GB202118144D0 (en) 2021-12-15 2021-12-15 Bicyclic peptide ligands specific for cathepsin G

Publications (1)

Publication Number Publication Date
GB202118144D0 true GB202118144D0 (en) 2022-01-26

Family

ID=80079998

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2118144.1A Ceased GB202118144D0 (en) 2021-12-15 2021-12-15 Bicyclic peptide ligands specific for cathepsin G

Country Status (1)

Country Link
GB (1) GB202118144D0 (en)

Similar Documents

Publication Publication Date Title
IL304241A (en) Heterotandem bicyclic peptide complexes
IL304211A (en) Anti-infective bicyclic peptide ligands
GB201900530D0 (en) Bicyclic peptide ligands specific for CD38
GB202118144D0 (en) Bicyclic peptide ligands specific for cathepsin G
GB202019994D0 (en) Bicyclic peptide ligands specific for Cathepsin G
GB202114283D0 (en) Bicyclic peptide ligands specific for cathepsin s
GB202015668D0 (en) Bicyclic peptide ligands specific for cathepsin s
GB201900529D0 (en) Bicyclic peptide ligands specific for CD38
GB201914197D0 (en) Bicyclic peptide ligands specific for cathepsin S
GB202002708D0 (en) Bicyclic peptide ligands specific for il-17
GB201820318D0 (en) Bicyclic peptide ligands specific for cathepsin G
GB202001591D0 (en) Bicyclic peptide ligands specific for human plasma kallikrein
GB201820307D0 (en) Bicyclic peptide ligands specific for cathepsin S
GB202118139D0 (en) Bicyclic peptide ligands specific for KLK5
GB202118136D0 (en) Bicyclic peptide ligands specific for Hsp90
GB202019988D0 (en) Bicyclic peptide ligands specific for hsp90
GB202103870D0 (en) Bicyclic peptide ligands specific for trem2
GB202118134D0 (en) Bicyclic peptide ligands specific for neutrophil elastase
GB202019985D0 (en) Bicyclic peptide ligands specific for neutrophil elastase
GB201918470D0 (en) Bicyclic peptide ligands specific for neutrophil elastase
GB201918558D0 (en) Bicyclic peptide ligands specific for IL-17
GB201918559D0 (en) Bicyclic peptide ligands specific for IL-17
GB201918557D0 (en) Bicyclic peptide ligands specific for IL-17
GB202118137D0 (en) Bicyclic peptide ligands specific for IL-6
GB201918495D0 (en) Bicyclic peptide ligands specific for il-46

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)